AMRC
Ameresco, Inc. NYSE Listed Jul 22, 2010$29.66
Mkt Cap $1.6B
52w Low $12.51
52.9% of range
52w High $44.93
50d MA $27.24
200d MA $29.86
P/E (TTM)
37.3x
EV/EBITDA
14.9x
P/B
1.5x
Debt/Equity
1.8x
ROE
5.5%
P/FCF
-3.5x
RSI (14)
—
ATR (14)
—
Beta
2.61
50d MA
$27.24
200d MA
$29.86
Avg Volume
521.8K
Ameresco, Inc., a clean technology integrator, provides a portfolio of energy efficiency and renewable energy supply solutions in the United States, Canada, and internationally. It offers energy efficiency, infrastructure upgrades, energy security and resilience, asset sustainability, and renewable energy solutions for businesses and organizations. The company operates through U.S. Regions, U.S. Federal, Canada, and Non-Solar Distributed Generation segments. It designs, develops, engineers, and installs projects that reduce the energy, as well as operations and maintenance (O&M) costs of its customers' facilities. The company's projects primarily include various measures customized for the facility and designed to enhance the efficiency of building systems, such as heating, ventilation, cooling, and lighting systems. It also offers renewable energy solutions and services, such as the construction of small-scale plants that the company owns or develops for customers that produce electricity, gas, heat, or cooling from renewable sources of energy and O&M services; and electricity, processed renewable gas fuel, and heat or cooling produced from renewable sources of energy. In addition, the company sells photovoltaic (PV) solar energy products and systems, as well as provides consulting and enterprise energy management services; and owns and operates a wind power project located in Ireland. It serves the federal, state, and local governments, as well as healthcare and educational institutions, airports, public housing authorities and public universities, and commercial and industrial customers. As of December 31, 2021, the company owned and operated 147 small-scale renewable energy plants and solar PV installations. Ameresco, Inc. was founded in 2000 and is headquartered in Framingham, Massachusetts.
111 Speen Street · Framingham, MA 01701 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | -0.27 | -0.33 | -22.2% | 31.48 | -5.6% | -2.3% | +2.5% | -5.9% | — | — | — |
| Mar 2, 2026 | AMC | 0.32 | 0.39 | +21.9% | 30.95 | +0.2% | -9.9% | +0.9% | -3.6% | -5.3% | +2.1% | — |
| Nov 3, 2025 | AMC | 0.26 | 0.35 | +34.6% | 40.00 | -8.5% | -9.3% | +3.2% | -2.2% | -3.6% | +1.8% | — |
| Aug 4, 2025 | AMC | 0.06 | 0.27 | +350.0% | 16.70 | +29.6% | +49.0% | -18.1% | -1.8% | +0.5% | -2.6% | — |
| May 5, 2025 | AMC | -0.26 | -0.11 | +57.7% | 11.63 | +20.4% | +11.8% | -2.5% | +4.1% | +1.3% | +8.9% | — |
| Feb 27, 2025 | AMC | 0.76 | 0.88 | +15.8% | 18.33 | -11.1% | -35.6% | -10.5% | -9.2% | +3.5% | -6.4% | — |
| Nov 7, 2024 | AMC | 0.47 | 0.33 | -29.8% | 31.64 | +1.1% | -16.3% | +8.0% | -7.5% | -0.6% | +1.9% | — |
| Aug 5, 2024 | AMC | 0.26 | 0.09 | -65.4% | 26.85 | -0.9% | +7.0% | -2.8% | +3.7% | -7.7% | -0.1% | — |
| May 7, 2024 | AMC | -0.11 | -0.10 | +9.1% | 22.24 | +7.0% | +21.1% | +3.8% | -1.2% | +3.4% | +5.0% | — |
| Feb 28, 2024 | AMC | 0.57 | 0.69 | +21.1% | 20.37 | +12.4% | +2.9% | -6.8% | -7.3% | +2.0% | +6.2% | — |
| Nov 6, 2023 | AMC | 0.46 | 0.40 | -13.0% | 26.61 | -19.0% | -14.9% | -4.2% | +4.7% | -1.9% | +1.0% | — |
| Jul 31, 2023 | AMC | 0.18 | 0.15 | -16.7% | 58.21 | -3.3% | -9.5% | -2.8% | +1.6% | -3.8% | +2.7% | — |
| May 1, 2023 | AMC | 0.03 | 0.03 | -9.9% | 40.78 | +9.4% | +10.0% | -5.8% | -2.2% | +4.1% | -1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 | UBS | Maintains | Neutral → Neutral | — | $26.28 | $26.26 | -0.1% | -6.0% | +3.6% | +2.1% | +2.1% | +0.6% |
| Mar 11 | Stifel | Maintains | Buy → Buy | — | $26.36 | $26.51 | +0.6% | -2.0% | +1.8% | -6.0% | +3.6% | +2.1% |
| Mar 4 | B. Riley Securities | Maintains | Buy → Buy | — | $27.90 | $28.73 | +3.0% | +0.9% | -3.6% | -5.3% | +2.1% | +0.5% |
| Mar 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $30.95 | $31.00 | +0.2% | -9.9% | +0.9% | -3.6% | -5.3% | +2.1% |
| Dec 3 | UBS | Maintains | Neutral → Neutral | — | $35.07 | $35.28 | +0.6% | -0.3% | -2.6% | -2.4% | -2.3% | -0.6% |
| Nov 14 | Stifel | Maintains | Buy → Buy | — | $31.52 | $31.49 | -0.1% | +2.0% | -3.4% | +0.2% | -0.4% | -1.6% |
| Nov 3 | Roth Capital | Maintains | Buy → Buy | — | $39.52 | $39.62 | +0.3% | +1.2% | -9.3% | +3.2% | -2.2% | -3.6% |
| Oct 31 | B. Riley Securities | Maintains | Buy → Buy | — | $38.97 | $39.38 | +1.1% | +1.4% | +1.2% | -9.3% | +3.2% | -2.2% |
| Sep 25 | Jefferies | Upgrade | Hold → Buy | — | $31.61 | $32.61 | +3.2% | +10.2% | -0.1% | -1.8% | -1.7% | +11.8% |
| Sep 10 | B. Riley Securities | Maintains | Buy → Buy | — | $24.87 | $26.05 | +4.7% | +12.7% | -2.5% | +0.2% | +5.1% | -1.5% |
| Sep 2 | Baird | Upgrade | Neutral → Outperform | — | $25.43 | $26.43 | +3.9% | +0.1% | +0.7% | +1.4% | -0.3% | -6.4% |
| Aug 18 | UBS | Upgrade | Sell → Neutral | — | $21.43 | $22.15 | +3.4% | +6.3% | -1.2% | +0.6% | +0.4% | +7.2% |
| Jul 23 | Jefferies | Maintains | Hold → Hold | — | $19.24 | $19.52 | +1.5% | +1.9% | -4.2% | -3.5% | -1.2% | -0.2% |
| Jun 3 | UBS | Maintains | Sell → Sell | — | $13.53 | $13.70 | +1.3% | +13.3% | -3.3% | +0.1% | +4.4% | +3.0% |
| May 12 | Stifel | Maintains | Buy → Buy | — | $13.36 | $14.01 | +4.9% | +8.9% | +0.1% | -2.5% | +3.9% | +1.4% |
| May 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $11.63 | $14.00 | +20.4% | +11.8% | -2.5% | +4.1% | +1.3% | +8.9% |
| May 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.63 | $14.00 | +20.4% | +11.8% | -2.5% | +4.1% | +1.3% | +8.9% |
| Apr 15 | Baird | Downgrade | Outperform → Neutral | — | $10.09 | $9.73 | -3.6% | -5.1% | +6.4% | -2.4% | -13.0% | +11.8% |
| Mar 5 | Stifel | Maintains | Buy → Buy | — | $9.59 | $9.76 | +1.8% | +3.5% | -6.4% | +19.4% | -6.8% | -0.2% |
| Mar 4 | UBS | Downgrade | Buy → Sell | — | $10.56 | $10.04 | -4.9% | -9.2% | +3.5% | -6.4% | +19.4% | -6.8% |
| Feb 28 | Baird | Maintains | Outperform → Outperform | — | $18.33 | $16.29 | -11.1% | -35.6% | -10.5% | -9.2% | +3.5% | -6.4% |
| Feb 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $18.33 | $16.29 | -11.1% | -35.6% | -10.5% | -9.2% | +3.5% | -6.4% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $18.39 | $18.37 | -0.1% | -0.8% | +0.4% | -35.6% | -10.5% | -9.2% |
| Nov 11 | Stifel | Maintains | Buy → Buy | — | $26.48 | $27.45 | +3.7% | +8.0% | -7.5% | -0.6% | +1.9% | -4.8% |
| Oct 22 | Piper Sandler | Maintains | Overweight → Overweight | — | $30.74 | $30.91 | +0.6% | -2.5% | +2.7% | +2.5% | -3.3% | +4.0% |
| Sep 23 | Baird | Maintains | Outperform → Outperform | — | $36.07 | $38.70 | +7.3% | +4.8% | -0.1% | -3.6% | +6.6% | -0.5% |
| Sep 5 | UBS | Maintains | Buy → Buy | — | $29.29 | $30.11 | +2.8% | +8.0% | -7.0% | +2.3% | +1.7% | +8.7% |
| Aug 27 | Baird | Maintains | Outperform → Outperform | — | $30.09 | $30.23 | +0.5% | -1.6% | -2.1% | +3.4% | +1.6% | -3.1% |
| Aug 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $26.85 | $26.62 | -0.9% | +7.0% | -2.8% | +3.7% | -7.7% | -0.1% |
| Jul 22 | Piper Sandler | Maintains | Overweight → Overweight | — | $31.51 | $33.32 | +5.7% | +4.1% | -1.4% | -2.6% | +2.6% | -4.4% |
| May 14 | UBS | Maintains | Buy → Buy | — | $28.56 | $29.86 | +4.6% | +5.0% | -6.4% | -2.3% | -0.2% | +2.2% |
| May 9 | Stifel | Maintains | Buy → Buy | — | $26.94 | $27.00 | +0.2% | +3.8% | -1.2% | +3.4% | +5.0% | -6.4% |
| May 9 | Baird | Maintains | Outperform → Outperform | — | $26.94 | $27.00 | +0.2% | +3.8% | -1.2% | +3.4% | +5.0% | -6.4% |
| Apr 22 | Truist | Maintains | Buy → Buy | — | $18.80 | $18.98 | +1.0% | +1.5% | +9.4% | +1.9% | -1.5% | +2.4% |
| Apr 17 | Oppenheimer | Maintains | Perform → Perform | — | $19.44 | $19.62 | +0.9% | -4.3% | -0.3% | +1.3% | +1.5% | +9.4% |
| Apr 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $23.12 | $22.82 | -1.3% | -2.1% | -7.6% | -3.9% | -3.3% | -4.3% |
| Apr 3 | Raymond James | Maintains | Outperform → Outperform | — | $23.86 | $23.49 | -1.6% | -1.6% | -3.0% | -1.3% | +1.8% | +5.3% |
| Mar 12 | Exane BNP Paribas | Upgrade | Neutral → Outperform | — | $21.32 | $22.01 | +3.2% | -2.4% | -1.0% | -2.1% | +5.3% | -1.1% |
| Mar 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $18.11 | $18.00 | -0.6% | +2.0% | +6.2% | +3.5% | +4.0% | +0.9% |
| Feb 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $20.37 | $22.90 | +12.4% | +2.9% | -6.8% | -7.3% | +2.0% | +6.2% |
| Feb 5 | B. Riley Securities | Maintains | Buy → Buy | — | $21.10 | $20.27 | -3.9% | -4.2% | +6.4% | +2.0% | +2.1% | +2.1% |
| Dec 15 | BofA Securities | Downgrade | Buy → Neutral | — | $36.52 | $36.28 | -0.7% | -7.3% | -5.4% | +3.2% | -7.2% | +2.6% |
| Nov 8 | Stifel | Maintains | Buy → Buy | — | $22.65 | $23.06 | +1.8% | -4.2% | +4.7% | -1.9% | +1.0% | +20.6% |
| Nov 7 | William Blair | Downgrade | Outperform → Market Perform | — | $26.61 | $21.55 | -19.0% | -14.9% | -4.2% | +4.7% | -1.9% | +1.0% |
| Nov 7 | Oppenheimer | Downgrade | Outperform → Perform | — | $26.61 | $21.55 | -19.0% | -14.9% | -4.2% | +4.7% | -1.9% | +1.0% |
| Nov 7 | Raymond James | Maintains | Outperform → Outperform | — | $26.61 | $21.55 | -19.0% | -14.9% | -4.2% | +4.7% | -1.9% | +1.0% |
| Oct 25 | Roth MKM | Upgrade | Neutral → Buy | — | $29.73 | $30.36 | +2.1% | -5.8% | -1.9% | -0.7% | +1.4% | -5.4% |
| Oct 12 | Oppenheimer | Maintains | Outperform → Outperform | — | $35.50 | $34.60 | -2.5% | -6.0% | -0.2% | +3.2% | +0.9% | -5.1% |
| Oct 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $33.09 | $32.52 | -1.7% | +0.3% | -1.9% | +9.9% | -0.8% | -6.0% |
| Oct 3 | Raymond James | Maintains | Outperform → Outperform | — | $35.41 | $34.99 | -1.2% | -4.5% | +4.2% | -6.1% | +0.3% | -1.9% |
No insider trades available.
8-K · 1.01
!! High
Ameresco, Inc. -- 8-K 1.01: Material Agreement
Ameresco contributes its biogas business to a joint venture with Hoth Therapeutics, retaining 70% equity interest through Class A units while transferring subsidiary stakes and related liabilities.
May 4
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Uncertainty regarding leadership transition at these financial institutions effective April 1, 2026, could trigger stock volatility as investors assess whether successor maintains current strategic direction and operational performance.
Mar 31
8-K
Unknown — 8-K Filing
IMSR's NRC design acceptance and DOE selection validates its commercial viability, potentially accelerating deployment timelines and reducing regulatory risk—crucial milestones justifying the $292 million investment for investors betting on advanced nuclear technology.
Mar 30
8-K
Ameresco, Inc. -- 8-K Filing
Ameresco reported fourth quarter 2025 financial results, providing investors updated performance metrics for the energy infrastructure solutions provider.
Mar 2
Data updated apr 24, 2026 5:55pm
· Source: massive.com